RESECTABLE LUNG NON-SMALL CELL CARCINOMA
Clinical trials for RESECTABLE LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aiming to spare lung cancer patients from chemo: a smarter Pre-Surgery plan?
Disease control Not yet recruitingThis phase 2 trial tests whether the immunotherapy drug cemiplimab can be used alone before surgery for certain patients with early-stage non-small cell lung cancer (NSCLC) that can be removed. The goal is to see if some patients can safely skip chemotherapy and its harsh side ef…
Matched conditions: RESECTABLE LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis study tests whether taking two drugs—firmonertinib (a targeted pill) and bevacizumab (an infusion)—for three months before surgery can shrink tumors in people with a specific type of lung cancer (EGFR-mutated, stage II-IIIB). After surgery, patients may continue firmonertini…
Matched conditions: RESECTABLE LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC